{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "#import library\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "import pandas as pd\n",
    "import sys\n",
    "sys.path.append('../../../../DataScience/lib/')\n",
    "import pymei\n",
    "from dev.bind_prod_utils import utils as dev_utils\n",
    "import numpy as np\n",
    "import race_ebm_funcs as ref"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter your jumpcloud username:  Leo.Zhou\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Enter your password:\n"
     ]
    },
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      " ················\n"
     ]
    }
   ],
   "source": [
    "# presto access credentials\n",
    "username = input('Enter your jumpcloud username: ')\n",
    "print('Enter your password:')\n",
    "conn = pymei.connect.presto(username=username, phi=True, starburst=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#get the original data from starburst\n",
    "end_date = input('EBM end date: ')\n",
    "race_ebm_df = ref.get_data(conn, end_date)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "# #filter the data based on the ebm end date, select the rows with specified ebm end date\n",
    "# end_date = input('EBM end date: ') #input need to be in format year-month. Ex. 2020-12\n",
    "# race_ebm_df  = ref.filter_end_date(race_ebm_df, end_date)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "#create another column for over/underuse\n",
    "#Create under/overuse based on EBM measure label\n",
    "underuse = [\n",
    "#'APP_TOTAL_2020',# - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (Total)',\n",
    "'PPC_PN_2020C',#  - Prenatal and Postpartum Care: Prenatal Care',\n",
    "'PPC_PP_2020C',#  - Prenatal and Postpartum Care: Postpartum Care',\n",
    "# 'ADD_R1_2020C',#  - Follow-Up Care for Children Prescribed ADHD Medication: Initiation Phase',\n",
    "# 'ADD_R2_2020C',#  - Follow-Up Care for Children Prescribed ADHD Medication: Continuation & Maintenance Phase',\n",
    "# 'FUA30_TOTAL_2020',#  - Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence : 30 days (Overall)',\n",
    "# 'FUA7_TOTAL_2020',#  - Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence : 07 days (Overall)',\n",
    "# 'FUH_30_TOTAL_2020',#  - Follow-Up After Hospitalization for Mental Illness: Total (30 Days Post-Discharge)',\n",
    "# 'FUH_7_TOTAL_2020',#  - Follow-Up After Hospitalization for Mental Illness: Total (7 Days Post-Discharge)',\n",
    "# 'FUM_30_TOTAL_2020',#  - Follow-Up After Emergency Department Visit for Mental Illness (Total)-30 Day Follow-Up',\n",
    "# 'FUM_7_TOTAL_2020',#  - Follow-Up After Emergency Department Visit for Mental Illness (Total)-7 Day Follow-Up',\n",
    "# 'SAA_2020',#  - Adherence to Antipsychotic Medications for Individuals with Schizophrenia',\n",
    "# 'SPC_R1_TOTAL_2020',#  - Statin Therapy for Patients with Cardiovascular Disease, Rate 1: Received Statin Therapy (Total)',\n",
    "# 'SPC_R2_TOTAL_2020',#  - Statin Therapy for Patients with Cardiovascular Disease, Rate 2: Statin Adherence 80% (Total)',\n",
    "'CDC_A1C_T_2020C',#  - Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Testing',\n",
    "'PQA_BB_2018',#  - Percentage of members 18 years and older who met the PDC threshold of 80% for beta-blockers during the measurement period.',\n",
    "'PQA_RASA_2018',#  - Percentage of members 18 years and older who met the PDC threshold of 80% for Renin Angiotensin System Antagonists during the measurement period.',\n",
    "#'NYU_EM_ED_PA_2016',#  - NYU ED Utilization Algorithm: Emergent, ED Care Needed, Preventable/Avoidable',\n",
    "#'NCS_2020',#  - Non-Recommended Cervical Cancer Screening in Adolescent Females',\n",
    "'BCS_NON_MCR_2020C',#  - Breast Cancer Screening',\n",
    "'CHL_TOTAL_2020C',#  - Chlamydia Screening in Women (Total)',\n",
    "'COL_NON_MCR_2020C',#  - Colorectal Cancer Screening',\n",
    "'IMA_HPV_2020',#  - Immunizations for Adolescents: HPV Vaccine',\n",
    "'IMA_MEN_2020',#  - Immunizations for Adolescents: Meningococcal Conjugate or Meningococcal Polysaccharide Vaccine',\n",
    "'IMA_TD_2020',#  - Immunizations for Adolescents: Tdap Vaccine',\n",
    "# 'W15_V00_2020C',#  - Well-Child Visits in the First 15 Months of Life: 0 Visits',\n",
    "# 'W15_V01_2020C',#  - Well-Child Visits in the First 15 Months of Life: 1 Visit',\n",
    "# 'W15_V02_2020C',#  - Well-Child Visits in the First 15 Months of Life: 2 Visits',\n",
    "# 'W15_V03_2020C',#  - Well-Child Visits in the First 15 Months of Life: 3 Visits',\n",
    "# 'W15_V04_2020C',#  - Well-Child Visits in the First 15 Months of Life: 4 Visits',\n",
    "# 'W15_V05_2020C',#  - Well-Child Visits in the First 15 Months of Life: 5 Visits',\n",
    "# 'W15',#_V06+_2020C - Well-Child Visits in the First 15 Months of Life: 6 or more Visits',\n",
    "'W34_2020C'#  - Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life'  \t\t\n",
    "           ]\n",
    "           \n",
    "\n",
    "overuse = [\n",
    "#'NYU_EM_PCT_2016',#  - NYU ED Utilization Algorithm: Emergent, Primary Care Treatable',\n",
    "'NYU_NON_EM_2016',#  - NYU ED Utilization Algorithm: Non-Emergent',\n",
    "'AAB_2020C',#  - Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (Total)',\n",
    "#'APC_TOTAL_2019',#  - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (Total)',\n",
    "'HDO_2020',#  - Use of Opioids at High Dosage',\n",
    "'LBP_2020C',#  - Use of Imaging Studies for Low Back Pain',\n",
    "'UOP_NUM1_2020',#  - Use of Opioids from Multiple Providers (Multiple Prescribers)',\n",
    "'UOP_NUM2_2020',#  - Use of Opioids from Multiple Providers (Multiple Pharmacies)',\n",
    "'UOP_NUM3_2020',#  - Use of Opioids from Multiple Providers (Multiple Prescribers and Multiple Pharmacies)',\n",
    "'URI_2020C',#  - Appropriate Treatment for Upper Respiratory Infection',\n",
    "'CWP_2020C',#  - Appropriate Testing for Pharyngitis (Total)',\n",
    "'IQI_21_TOTAL_2017'#,  - Cesarean Delivery Rate, Uncomplicated (Overall)',\n",
    "#'IQI_34_TOTAL_2017'#  - Vaginal Birth After Cesarean (VBAC) Rate, All (Overall)'\n",
    "          ]\n",
    "\n",
    "race_ebm_df = ref.add_ebm_col(overuse, underuse, race_ebm_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "race_ebm_df = ref.convert_cat(race_ebm_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "#save separate datasets for underuse and overuse\n",
    "race_ebm_df.to_csv(r'.../restricted /main_race_ebm_analysis.csv', index = False)\n",
    "\n",
    "overuse_df = race_ebm_df[race_ebm_df['over/underuse'] == 'over']\n",
    "overuse_df.to_csv(r'.../restricted /main_overuse_df.csv', index = False)\n",
    "\n",
    "underuse_df = race_ebm_df[race_ebm_df['over/underuse'] == 'under']\n",
    "underuse_df.to_csv(r'.../restricted /main_underuse_df.csv', index = False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "#read the datasets \n",
    "race_ebm_df = pd.read_csv ('.../restricted /main_race_ebm_analysis.csv')\n",
    "over_df = pd.read_csv ('.../restricted /main_overuse_df.csv')\n",
    "under_df = pd.read_csv ('.../restricted /main_underuse_df.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "white       0.780401\n",
       "black       0.095212\n",
       "hispanic    0.086192\n",
       "api         0.036397\n",
       "aian        0.001566\n",
       "2prace      0.000232\n",
       "Name: predicted_race, dtype: float64"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#get the race proportion table\n",
    "ref.race_prop_tab(race_ebm_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>white</th>\n",
       "      <th>black</th>\n",
       "      <th>hispanic</th>\n",
       "      <th>api</th>\n",
       "      <th>aian</th>\n",
       "      <th>2prace</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>over</th>\n",
       "      <td>0.287607</td>\n",
       "      <td>0.257105</td>\n",
       "      <td>0.263403</td>\n",
       "      <td>0.354470</td>\n",
       "      <td>0.162222</td>\n",
       "      <td>0.3325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>under</th>\n",
       "      <td>0.407171</td>\n",
       "      <td>0.375201</td>\n",
       "      <td>0.356789</td>\n",
       "      <td>0.418663</td>\n",
       "      <td>0.277407</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          white     black  hispanic       api      aian  2prace\n",
       "over   0.287607  0.257105  0.263403  0.354470  0.162222  0.3325\n",
       "under  0.407171  0.375201  0.356789  0.418663  0.277407  0.0000"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#overuse underuse vs. race\n",
    "ref.over_under_tab(race_ebm_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>White</th>\n",
       "      <th>Black</th>\n",
       "      <th>Hispanic</th>\n",
       "      <th>API</th>\n",
       "      <th>AIAN</th>\n",
       "      <th>2prace</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ebm_measure_label</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>AAB_2020C - Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (Total)</th>\n",
       "      <td>0.553398</td>\n",
       "      <td>0.687500</td>\n",
       "      <td>0.423077</td>\n",
       "      <td>0.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>APC_TOTAL_2019 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (Total)</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CWP_2020C - Appropriate Testing for Pharyngitis (Total)</th>\n",
       "      <td>0.731219</td>\n",
       "      <td>0.454545</td>\n",
       "      <td>0.523810</td>\n",
       "      <td>0.636364</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>HDO_2020 - Use of Opioids at High Dosage</th>\n",
       "      <td>0.026059</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.047619</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IQI_21_TOTAL_2017 - Cesarean Delivery Rate, Uncomplicated (Overall)</th>\n",
       "      <td>0.270451</td>\n",
       "      <td>0.354839</td>\n",
       "      <td>0.264151</td>\n",
       "      <td>0.327869</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IQI_34_TOTAL_2017 - Vaginal Birth After Cesarean (VBAC) Rate, All (Overall)</th>\n",
       "      <td>0.117647</td>\n",
       "      <td>0.230769</td>\n",
       "      <td>0.100000</td>\n",
       "      <td>0.076923</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>LBP_2020C - Use of Imaging Studies for Low Back Pain</th>\n",
       "      <td>0.772989</td>\n",
       "      <td>0.756098</td>\n",
       "      <td>0.612903</td>\n",
       "      <td>0.882353</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NYU_EM_PCT_2016 - NYU ED Utilization Algorithm: Emergent, Primary Care Treatable</th>\n",
       "      <td>0.201490</td>\n",
       "      <td>0.221696</td>\n",
       "      <td>0.206104</td>\n",
       "      <td>0.185906</td>\n",
       "      <td>0.066667</td>\n",
       "      <td>0.33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NYU_NON_EM_2016 - NYU ED Utilization Algorithm: Non-Emergent</th>\n",
       "      <td>0.171181</td>\n",
       "      <td>0.232587</td>\n",
       "      <td>0.197878</td>\n",
       "      <td>0.162063</td>\n",
       "      <td>0.097500</td>\n",
       "      <td>0.00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UOP_NUM1_2020 - Use of Opioids from Multiple Providers (Multiple Prescribers)</th>\n",
       "      <td>0.145251</td>\n",
       "      <td>0.132075</td>\n",
       "      <td>0.125000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UOP_NUM2_2020 - Use of Opioids from Multiple Providers (Multiple Pharmacies)</th>\n",
       "      <td>0.036313</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UOP_NUM3_2020 - Use of Opioids from Multiple Providers (Multiple Prescribers and Multiple Pharmacies)</th>\n",
       "      <td>0.016760</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>URI_2020C - Appropriate Treatment for Upper Respiratory Infection</th>\n",
       "      <td>0.894231</td>\n",
       "      <td>0.828571</td>\n",
       "      <td>0.806122</td>\n",
       "      <td>0.876923</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                       White     Black  \\\n",
       "ebm_measure_label                                                        \n",
       "AAB_2020C - Avoidance of Antibiotic Treatment f...  0.553398  0.687500   \n",
       "APC_TOTAL_2019 - Use of Multiple Concurrent Ant...  0.000000  0.000000   \n",
       "CWP_2020C - Appropriate Testing for Pharyngitis...  0.731219  0.454545   \n",
       "HDO_2020 - Use of Opioids at High Dosage            0.026059  0.000000   \n",
       "IQI_21_TOTAL_2017 - Cesarean Delivery Rate, Unc...  0.270451  0.354839   \n",
       "IQI_34_TOTAL_2017 - Vaginal Birth After Cesarea...  0.117647  0.230769   \n",
       "LBP_2020C - Use of Imaging Studies for Low Back...  0.772989  0.756098   \n",
       "NYU_EM_PCT_2016 - NYU ED Utilization Algorithm:...  0.201490  0.221696   \n",
       "NYU_NON_EM_2016 - NYU ED Utilization Algorithm:...  0.171181  0.232587   \n",
       "UOP_NUM1_2020 - Use of Opioids from Multiple Pr...  0.145251  0.132075   \n",
       "UOP_NUM2_2020 - Use of Opioids from Multiple Pr...  0.036313  0.000000   \n",
       "UOP_NUM3_2020 - Use of Opioids from Multiple Pr...  0.016760  0.000000   \n",
       "URI_2020C - Appropriate Treatment for Upper Res...  0.894231  0.828571   \n",
       "\n",
       "                                                    Hispanic       API  \\\n",
       "ebm_measure_label                                                        \n",
       "AAB_2020C - Avoidance of Antibiotic Treatment f...  0.423077  0.750000   \n",
       "APC_TOTAL_2019 - Use of Multiple Concurrent Ant...  0.000000       NaN   \n",
       "CWP_2020C - Appropriate Testing for Pharyngitis...  0.523810  0.636364   \n",
       "HDO_2020 - Use of Opioids at High Dosage            0.047619  0.000000   \n",
       "IQI_21_TOTAL_2017 - Cesarean Delivery Rate, Unc...  0.264151  0.327869   \n",
       "IQI_34_TOTAL_2017 - Vaginal Birth After Cesarea...  0.100000  0.076923   \n",
       "LBP_2020C - Use of Imaging Studies for Low Back...  0.612903  0.882353   \n",
       "NYU_EM_PCT_2016 - NYU ED Utilization Algorithm:...  0.206104  0.185906   \n",
       "NYU_NON_EM_2016 - NYU ED Utilization Algorithm:...  0.197878  0.162063   \n",
       "UOP_NUM1_2020 - Use of Opioids from Multiple Pr...  0.125000  0.000000   \n",
       "UOP_NUM2_2020 - Use of Opioids from Multiple Pr...  0.000000  0.000000   \n",
       "UOP_NUM3_2020 - Use of Opioids from Multiple Pr...  0.000000  0.000000   \n",
       "URI_2020C - Appropriate Treatment for Upper Res...  0.806122  0.876923   \n",
       "\n",
       "                                                        AIAN  2prace  \n",
       "ebm_measure_label                                                     \n",
       "AAB_2020C - Avoidance of Antibiotic Treatment f...       NaN     NaN  \n",
       "APC_TOTAL_2019 - Use of Multiple Concurrent Ant...       NaN     NaN  \n",
       "CWP_2020C - Appropriate Testing for Pharyngitis...       NaN     NaN  \n",
       "HDO_2020 - Use of Opioids at High Dosage            0.000000     NaN  \n",
       "IQI_21_TOTAL_2017 - Cesarean Delivery Rate, Unc...  1.000000    0.00  \n",
       "IQI_34_TOTAL_2017 - Vaginal Birth After Cesarea...  0.000000     NaN  \n",
       "LBP_2020C - Use of Imaging Studies for Low Back...  1.000000     NaN  \n",
       "NYU_EM_PCT_2016 - NYU ED Utilization Algorithm:...  0.066667    0.33  \n",
       "NYU_NON_EM_2016 - NYU ED Utilization Algorithm:...  0.097500    0.00  \n",
       "UOP_NUM1_2020 - Use of Opioids from Multiple Pr...  0.500000     NaN  \n",
       "UOP_NUM2_2020 - Use of Opioids from Multiple Pr...  0.000000     NaN  \n",
       "UOP_NUM3_2020 - Use of Opioids from Multiple Pr...  0.000000     NaN  \n",
       "URI_2020C - Appropriate Treatment for Upper Res...       NaN    1.00  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#table for overuse measures by race \n",
    "ref.ebm_tab(over_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>White</th>\n",
       "      <th>Black</th>\n",
       "      <th>Hispanic</th>\n",
       "      <th>API</th>\n",
       "      <th>AIAN</th>\n",
       "      <th>2prace</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ebm_measure_label</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>ADD_R1_2020C - Follow-Up Care for Children Prescribed ADHD Medication: Initiation Phase</th>\n",
       "      <td>0.526316</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ADD_R2_2020C - Follow-Up Care for Children Prescribed ADHD Medication: Continuation &amp; Maintenance Phase</th>\n",
       "      <td>0.555556</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>APP_TOTAL_2020 - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (Total)</th>\n",
       "      <td>0.545455</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CDC_A1C_T_2020C - Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Testing</th>\n",
       "      <td>0.822818</td>\n",
       "      <td>0.807487</td>\n",
       "      <td>0.760870</td>\n",
       "      <td>0.873239</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CHL_TOTAL_2020C - Chlamydia Screening in Women (Total)</th>\n",
       "      <td>0.340292</td>\n",
       "      <td>0.529412</td>\n",
       "      <td>0.413793</td>\n",
       "      <td>0.357143</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>COL_NON_MCR_2020C - Colorectal Cancer Screening</th>\n",
       "      <td>0.232938</td>\n",
       "      <td>0.350000</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>0.161290</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUA30_TOTAL_2020 - Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence : 30 days (Overall)</th>\n",
       "      <td>0.200000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUA7_TOTAL_2020 - Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence : 07 days (Overall)</th>\n",
       "      <td>0.200000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUH_30_TOTAL_2020 - Follow-Up After Hospitalization for Mental Illness: Total (30 Days Post-Discharge)</th>\n",
       "      <td>0.726190</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.800000</td>\n",
       "      <td>0.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUH_7_TOTAL_2020 - Follow-Up After Hospitalization for Mental Illness: Total (7 Days Post-Discharge)</th>\n",
       "      <td>0.511628</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.600000</td>\n",
       "      <td>0.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUM_30_TOTAL_2020 - Follow-Up After Emergency Department Visit for Mental Illness (Total)-30 Day Follow-Up</th>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FUM_7_TOTAL_2020 - Follow-Up After Emergency Department Visit for Mental Illness (Total)-7 Day Follow-Up</th>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.571429</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IMA_HPV_2020 - Immunizations for Adolescents: HPV Vaccine</th>\n",
       "      <td>0.082278</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IMA_MEN_2020 - Immunizations for Adolescents: Meningococcal Conjugate or Meningococcal Polysaccharide Vaccine</th>\n",
       "      <td>0.354430</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IMA_TD_2020 - Immunizations for Adolescents: Tdap Vaccine</th>\n",
       "      <td>0.316456</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.076923</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCS_2020 - Non-Recommended Cervical Cancer Screening in Adolescent Females</th>\n",
       "      <td>0.005198</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NYU_EM_ED_PA_2016 - NYU ED Utilization Algorithm: Emergent, ED Care Needed, Preventable/Avoidable</th>\n",
       "      <td>0.040674</td>\n",
       "      <td>0.062576</td>\n",
       "      <td>0.047996</td>\n",
       "      <td>0.034508</td>\n",
       "      <td>0.054444</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PPC_PN_2020C - Prenatal and Postpartum Care: Prenatal Care</th>\n",
       "      <td>0.328622</td>\n",
       "      <td>0.535714</td>\n",
       "      <td>0.480000</td>\n",
       "      <td>0.322581</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PPC_PP_2020C - Prenatal and Postpartum Care: Postpartum Care</th>\n",
       "      <td>0.480565</td>\n",
       "      <td>0.535714</td>\n",
       "      <td>0.360000</td>\n",
       "      <td>0.516129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PQA_BB_2018 - Percentage of members 18 years and older who met the PDC threshold of 80% for beta-blockers during the measurement period.</th>\n",
       "      <td>0.668797</td>\n",
       "      <td>0.446429</td>\n",
       "      <td>0.608696</td>\n",
       "      <td>0.619048</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PQA_RASA_2018 - Percentage of members 18 years and older who met the PDC threshold of 80% for Renin Angiotensin System Antagonists during the measurement period.</th>\n",
       "      <td>0.756384</td>\n",
       "      <td>0.594771</td>\n",
       "      <td>0.630435</td>\n",
       "      <td>0.674157</td>\n",
       "      <td>0.750000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SAA_2020 - Adherence to Antipsychotic Medications for Individuals with Schizophrenia</th>\n",
       "      <td>0.777778</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SPC_R1_TOTAL_2020 - Statin Therapy for Patients with Cardiovascular Disease, Rate 1: Received Statin Therapy (Total)</th>\n",
       "      <td>0.928571</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SPC_R2_TOTAL_2020 - Statin Therapy for Patients with Cardiovascular Disease, Rate 2: Statin Adherence 80% (Total)</th>\n",
       "      <td>0.769231</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V00_2020C - Well-Child Visits in the First 15 Months of Life: 0 Visits</th>\n",
       "      <td>0.018018</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V01_2020C - Well-Child Visits in the First 15 Months of Life: 1 Visit</th>\n",
       "      <td>0.009009</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V02_2020C - Well-Child Visits in the First 15 Months of Life: 2 Visits</th>\n",
       "      <td>0.027027</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V03_2020C - Well-Child Visits in the First 15 Months of Life: 3 Visits</th>\n",
       "      <td>0.018018</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V04_2020C - Well-Child Visits in the First 15 Months of Life: 4 Visits</th>\n",
       "      <td>0.063063</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.125000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V05_2020C - Well-Child Visits in the First 15 Months of Life: 5 Visits</th>\n",
       "      <td>0.198198</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W15_V06+_2020C - Well-Child Visits in the First 15 Months of Life: 6 or more Visits</th>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.750000</td>\n",
       "      <td>0.625000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>W34_2020C - Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life</th>\n",
       "      <td>0.700759</td>\n",
       "      <td>0.562500</td>\n",
       "      <td>0.662338</td>\n",
       "      <td>0.671569</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                       White     Black  \\\n",
       "ebm_measure_label                                                        \n",
       "ADD_R1_2020C - Follow-Up Care for Children Pres...  0.526316  1.000000   \n",
       "ADD_R2_2020C - Follow-Up Care for Children Pres...  0.555556       NaN   \n",
       "APP_TOTAL_2020 - Use of First-Line Psychosocial...  0.545455  1.000000   \n",
       "CDC_A1C_T_2020C - Comprehensive Diabetes Care: ...  0.822818  0.807487   \n",
       "CHL_TOTAL_2020C - Chlamydia Screening in Women ...  0.340292  0.529412   \n",
       "COL_NON_MCR_2020C - Colorectal Cancer Screening     0.232938  0.350000   \n",
       "FUA30_TOTAL_2020 - Follow-Up After Emergency De...  0.200000  0.000000   \n",
       "FUA7_TOTAL_2020 - Follow-Up After Emergency Dep...  0.200000  0.000000   \n",
       "FUH_30_TOTAL_2020 - Follow-Up After Hospitaliza...  0.726190  0.500000   \n",
       "FUH_7_TOTAL_2020 - Follow-Up After Hospitalizat...  0.511628  0.500000   \n",
       "FUM_30_TOTAL_2020 - Follow-Up After Emergency D...  0.666667  0.666667   \n",
       "FUM_7_TOTAL_2020 - Follow-Up After Emergency De...  0.400000  0.571429   \n",
       "IMA_HPV_2020 - Immunizations for Adolescents: H...  0.082278  0.000000   \n",
       "IMA_MEN_2020 - Immunizations for Adolescents: M...  0.354430  0.000000   \n",
       "IMA_TD_2020 - Immunizations for Adolescents: Td...  0.316456  0.000000   \n",
       "NCS_2020 - Non-Recommended Cervical Cancer Scre...  0.005198  0.000000   \n",
       "NYU_EM_ED_PA_2016 - NYU ED Utilization Algorith...  0.040674  0.062576   \n",
       "PPC_PN_2020C - Prenatal and Postpartum Care: Pr...  0.328622  0.535714   \n",
       "PPC_PP_2020C - Prenatal and Postpartum Care: Po...  0.480565  0.535714   \n",
       "PQA_BB_2018 - Percentage of members 18 years an...  0.668797  0.446429   \n",
       "PQA_RASA_2018 - Percentage of members 18 years ...  0.756384  0.594771   \n",
       "SAA_2020 - Adherence to Antipsychotic Medicatio...  0.777778  0.000000   \n",
       "SPC_R1_TOTAL_2020 - Statin Therapy for Patients...  0.928571  1.000000   \n",
       "SPC_R2_TOTAL_2020 - Statin Therapy for Patients...  0.769231  0.000000   \n",
       "W15_V00_2020C - Well-Child Visits in the First ...  0.018018  0.000000   \n",
       "W15_V01_2020C - Well-Child Visits in the First ...  0.009009  0.000000   \n",
       "W15_V02_2020C - Well-Child Visits in the First ...  0.027027  0.000000   \n",
       "W15_V03_2020C - Well-Child Visits in the First ...  0.018018  0.000000   \n",
       "W15_V04_2020C - Well-Child Visits in the First ...  0.063063  0.000000   \n",
       "W15_V05_2020C - Well-Child Visits in the First ...  0.198198  0.666667   \n",
       "W15_V06+_2020C - Well-Child Visits in the First...  0.666667  0.333333   \n",
       "W34_2020C - Well-Child Visits in the Third, Fou...  0.700759  0.562500   \n",
       "\n",
       "                                                    Hispanic       API  \\\n",
       "ebm_measure_label                                                        \n",
       "ADD_R1_2020C - Follow-Up Care for Children Pres...  1.000000       NaN   \n",
       "ADD_R2_2020C - Follow-Up Care for Children Pres...       NaN       NaN   \n",
       "APP_TOTAL_2020 - Use of First-Line Psychosocial...       NaN       NaN   \n",
       "CDC_A1C_T_2020C - Comprehensive Diabetes Care: ...  0.760870  0.873239   \n",
       "CHL_TOTAL_2020C - Chlamydia Screening in Women ...  0.413793  0.357143   \n",
       "COL_NON_MCR_2020C - Colorectal Cancer Screening     0.166667  0.161290   \n",
       "FUA30_TOTAL_2020 - Follow-Up After Emergency De...  0.000000  0.000000   \n",
       "FUA7_TOTAL_2020 - Follow-Up After Emergency Dep...  0.000000  0.000000   \n",
       "FUH_30_TOTAL_2020 - Follow-Up After Hospitaliza...  0.800000  0.750000   \n",
       "FUH_7_TOTAL_2020 - Follow-Up After Hospitalizat...  0.600000  0.750000   \n",
       "FUM_30_TOTAL_2020 - Follow-Up After Emergency D...  0.500000  1.000000   \n",
       "FUM_7_TOTAL_2020 - Follow-Up After Emergency De...  0.400000  0.000000   \n",
       "IMA_HPV_2020 - Immunizations for Adolescents: H...  0.000000  0.166667   \n",
       "IMA_MEN_2020 - Immunizations for Adolescents: M...  0.153846  0.250000   \n",
       "IMA_TD_2020 - Immunizations for Adolescents: Td...  0.076923  0.250000   \n",
       "NCS_2020 - Non-Recommended Cervical Cancer Scre...  0.000000  0.000000   \n",
       "NYU_EM_ED_PA_2016 - NYU ED Utilization Algorith...  0.047996  0.034508   \n",
       "PPC_PN_2020C - Prenatal and Postpartum Care: Pr...  0.480000  0.322581   \n",
       "PPC_PP_2020C - Prenatal and Postpartum Care: Po...  0.360000  0.516129   \n",
       "PQA_BB_2018 - Percentage of members 18 years an...  0.608696  0.619048   \n",
       "PQA_RASA_2018 - Percentage of members 18 years ...  0.630435  0.674157   \n",
       "SAA_2020 - Adherence to Antipsychotic Medicatio...  0.000000  0.000000   \n",
       "SPC_R1_TOTAL_2020 - Statin Therapy for Patients...  1.000000  1.000000   \n",
       "SPC_R2_TOTAL_2020 - Statin Therapy for Patients...  1.000000  0.000000   \n",
       "W15_V00_2020C - Well-Child Visits in the First ...  0.000000  0.000000   \n",
       "W15_V01_2020C - Well-Child Visits in the First ...  0.000000  0.000000   \n",
       "W15_V02_2020C - Well-Child Visits in the First ...  0.000000  0.000000   \n",
       "W15_V03_2020C - Well-Child Visits in the First ...  0.000000  0.000000   \n",
       "W15_V04_2020C - Well-Child Visits in the First ...  0.250000  0.125000   \n",
       "W15_V05_2020C - Well-Child Visits in the First ...  0.000000  0.250000   \n",
       "W15_V06+_2020C - Well-Child Visits in the First...  0.750000  0.625000   \n",
       "W34_2020C - Well-Child Visits in the Third, Fou...  0.662338  0.671569   \n",
       "\n",
       "                                                        AIAN  2prace  \n",
       "ebm_measure_label                                                     \n",
       "ADD_R1_2020C - Follow-Up Care for Children Pres...       NaN     NaN  \n",
       "ADD_R2_2020C - Follow-Up Care for Children Pres...       NaN     NaN  \n",
       "APP_TOTAL_2020 - Use of First-Line Psychosocial...       NaN     NaN  \n",
       "CDC_A1C_T_2020C - Comprehensive Diabetes Care: ...  1.000000     NaN  \n",
       "CHL_TOTAL_2020C - Chlamydia Screening in Women ...  0.250000     0.0  \n",
       "COL_NON_MCR_2020C - Colorectal Cancer Screening     0.000000     NaN  \n",
       "FUA30_TOTAL_2020 - Follow-Up After Emergency De...       NaN     NaN  \n",
       "FUA7_TOTAL_2020 - Follow-Up After Emergency Dep...       NaN     NaN  \n",
       "FUH_30_TOTAL_2020 - Follow-Up After Hospitaliza...       NaN     NaN  \n",
       "FUH_7_TOTAL_2020 - Follow-Up After Hospitalizat...       NaN     NaN  \n",
       "FUM_30_TOTAL_2020 - Follow-Up After Emergency D...       NaN     NaN  \n",
       "FUM_7_TOTAL_2020 - Follow-Up After Emergency De...       NaN     NaN  \n",
       "IMA_HPV_2020 - Immunizations for Adolescents: H...  0.000000     NaN  \n",
       "IMA_MEN_2020 - Immunizations for Adolescents: M...  0.000000     NaN  \n",
       "IMA_TD_2020 - Immunizations for Adolescents: Td...  0.000000     NaN  \n",
       "NCS_2020 - Non-Recommended Cervical Cancer Scre...  0.000000     0.0  \n",
       "NYU_EM_ED_PA_2016 - NYU ED Utilization Algorith...  0.054444     0.0  \n",
       "PPC_PN_2020C - Prenatal and Postpartum Care: Pr...       NaN     NaN  \n",
       "PPC_PP_2020C - Prenatal and Postpartum Care: Po...       NaN     NaN  \n",
       "PQA_BB_2018 - Percentage of members 18 years an...  1.000000     NaN  \n",
       "PQA_RASA_2018 - Percentage of members 18 years ...  0.750000     NaN  \n",
       "SAA_2020 - Adherence to Antipsychotic Medicatio...       NaN     NaN  \n",
       "SPC_R1_TOTAL_2020 - Statin Therapy for Patients...       NaN     NaN  \n",
       "SPC_R2_TOTAL_2020 - Statin Therapy for Patients...       NaN     NaN  \n",
       "W15_V00_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V01_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V02_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V03_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V04_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V05_2020C - Well-Child Visits in the First ...       NaN     NaN  \n",
       "W15_V06+_2020C - Well-Child Visits in the First...       NaN     NaN  \n",
       "W34_2020C - Well-Child Visits in the Third, Fou...       NaN     0.0  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#table for underuse measures by race \n",
    "ref.ebm_tab(under_df)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
